Thurston Springer Miller Herd & Titak’s Moderna MRNA Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.2K	Hold	145	–	–	﹤0.01%	841
2026 Q1	$7.37K	Hold	145	–	–	﹤0.01%	970
2025 Q4	$4.28K	Buy	145 +45	+45%	+$1.22K	﹤0.01%	1122
2025 Q3	$2.58K	Sell	100 -69	-41%	-$1.93K	0.01%	461
2025 Q2	$4.66K	Buy	169 +58	+52%	+$1.53K	﹤0.01%	1300
2025 Q1	$3.15K	Hold	111	–	–	﹤0.01%	1368
2024 Q4	$4.62K	Hold	111	–	–	﹤0.01%	1030
2024 Q3	$7.42K	Hold	111	–	–	﹤0.01%	1121
2024 Q2	$13.2K	Buy	+111	New	+$14K	﹤0.01%	923

Other funds holding MRNA

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

REX Advisers Fairfield, Connecticut $37.3M AUM

BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return

Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return

Mirabaud & Cie Geneva, Switzerland $249M AUM 43.75% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return